Time Stamps
[00:00] Laurence explains biotech to a five-year-old
[01:55] Early life in the UK and first steps toward biotech
[02:47] How The Double Helix and Celltech shaped his path
[07:15] Moving from bench science to Cell and a wider view of research
[13:04] Learning business development at Millennium
[15:30] Why relationships matter in biotech deals
[17:43] How Millennium changed from platform company to drug developer
[28:01] Joining Alnylam and building around RNAi
[39:19] Becoming a CEO at Warp Drive Bio
[44:36] Novel antibiotics, molecular glues, and the RevMed merger
[52:07] What founders should know about building to make a lasting impact
[54:50] Joining Decibel during restructuring and COVID
[58:55] Rebuilding culture and sharpening strategy
[1:09:49] Why Decibel focused on gene therapy for the inner ear
[1:25:05] Advice for founders raising money in a hard market
